Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

SNDL Inc.

Aurora just "beat" on sales -- but its losses this past quarter were mind-boggling.

Why Aurora Cannabis, Canopy, and Sundial Stocks Popped on Friday

SMITHS FALLS, ON , May 13, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the fourth quarter and fiscal year 2022 ended March 31, 2022, before financial markets open on May 27, 2022. Following the release of its fourth quarter and fiscal year 2022 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO at 10:00 AM Eastern Time on May 27, 2022.

Canopy Growth to Report Fourth Quarter and Fiscal Year 2022 Financial Results on May 27, 2022

Abbott Labs

Alcon Inc. - Registered Shares

Haemonetics

Intuitive Surgical

Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how CGC, HAE and ALC are poised ahead of their earnings releases.

3 Medical Product Stocks Set to Beat on Earnings This Season

Cronos Group

Tilray Brands

3 Canadian Marijuana Stocks To Watch This Upcoming Week The post 3 Canadian Marijuana Stocks To Watch Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Watch Next Week

Canopy Growth has said it had established new senior roles to be held by former higher-ups at Constellation Brands. Is CGC stock a buy now?

Any Reason To Buy Canopy Growth After More Job Cuts?

Shares of several companies in the broader cannabis and consumer discretionary sector, including Canopy Growth Corp (NASDAQ: CGC), are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement. The Federal Reserve raised its target fed funds rate.

What's Going On With Canopy Growth Shares Today?

Canopy Growth was once the top stock to own in cannabis. Bulls previously cited the large $4 billion cash hoard as a reason to buy: the company now has a net debt position.

Can Canopy Growth's Stock Price Recover To $10?

CGC stock has delivered losses for two years despite cannabis legalization on Canada. The company will not generate profits soon.

Is Canopy Growth a Buy After its Announcement to Cut Costs?

Netflix

Upstart Holdings

Some of these stocks are already great-looking investments right now.

3 Growth Stocks Investors Shouldn't Pass Up If They Continue Falling

Will CGC stock become a penny stock in 2022? The post Will Canopy Growth (CGC) Be On Your List Of Penny Stocks In 2022?

Will Canopy Growth (CGC) Be On Your List Of Penny Stocks In 2022?

Canopy Growth Corp. CGC, -4.85% WEED, -3.54% is laying off about 250 employees as result of cost-cutting measures, a spokesperson for the cannabis company told MarketWatch. Canopy Growth on Tuesday said it expects to generate cost savings of C$30 million ($23.4 million) to C$50 million and reduce SG&A expenses by C$70 million to C$100 million within 12 to 18 months, in addition to its previously announced cost savings of C$150 million to C$200 million.

Canopy growth eliminating about 250 jobs in cost-cutting move

Canopy Growth Corp said it would lay off about 250 employees as part of a cost-cutting plan as the Canadian pot producer tries to achieve long-elusive profitability.

Pot producer Canopy to cut 250 jobs in profitability bid

Strategic adjustments are expected to generate savings of $100 – $150 million within 12 – 18 months SMITHS FALLS, ON , April 26, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ:  CGC ), a world-leading diversified cannabis, hemp, and cannabis device company, today announced that the Company is undertaking a series of initiatives to reduce costs and drive efficiency in order to accelerate its path to profitability. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

Canopy Growth Announces Cost Reduction Actions to Accelerate Path to Profitability

BAD ETF

Bally's

International Game Technology

MGM Resorts

Penn Entertainment

Boston Beer Company

Constellation Brands

Wynn Resorts

Here are the nine sin stocks (alcohol stocks, cannabis stocks, gambling stocks, sports betting stocks, etc.) to keep on your radar: MGM: More Than a Casino Stock You could say that MGM Resorts International (MGM) is a global leader in the entertainment industry, but that would be putting it lightly.

9 Sin Stocks For Your Watchlist: Alcohol, Cannabis & Casinos

4/20 is a time to celebrate the cannabis plant and industry but also a time to reflect on how much further we still need to go. Reginald Stanfield started JustinCredible Cultivation, the first non-equity, Black-Owned Cannabis Cultivation in Massachusetts.

Cultivating Change In Cannabis (Podcast Transcript)

Curaleaf Holdings, Inc.

Best Pot Stocks To Add To Your Watch List Before May The post Are Top Marijuana Stocks A Buy Before May? 2 Top Pot Stocks While Cannabis Stocks Are Down appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Top Marijuana Stocks A Buy Before May? 2 Top Pot Stocks While Cannabis Stocks Are Down

With no foreseeable legal catalysts and a rough economic environment, CGC stock will likely face pressure for the next few months. The post Sadly for Canopy Growth, the Fed Is on a Different Kind of High appeared first on InvestorPlace.

Sadly for Canopy Growth, the Fed Is on a Different Kind of High

Canadian companies would get a boost out of legalization in the U.S.

Why Cannabis Investors Aren't Having a Happy 4/20

Clever Leaves Holdings Inc

Leafly Holdings

Traditionally in the U.S., April 20 is viewed as a holiday which celebrates marijuana. As a result, cannabis stocks are in focus.

Cannabis Stocks Alert: Why Are SNDL, CLVR, TLRY, CGC, LFLY Stocks on Watch Today?

CGC stock deserves more credit than Wall Street currently gives it. It can shine brighter over time and without regulatory shackles.

Canopy Growth Stock Bullish Thesis Is Alive and Well

Profitability seems to be a long way off for Canadian cannabis companies.

Here's Why Pot Stocks Should Stop Promising Profits

Cultivating Change In Cannabis

If you asked me to summarize my take on CGC stock, it may sound cliché, but to borrow a popular phrase somewhat related to this topic, I would reply, "just say no." The post As Pot Reform News Fades, Avoid Canopy Growth Stock appeared first on InvestorPlace.

As Pot Reform News Fades, Avoid Canopy Growth Stock

The profitless cannabis business is poised for further downside due to weakening financials and a poor outlook. The post Canopy Growth: The Bearish Trend Is Not Expected to Relieve appeared first on InvestorPlace.

Canopy Growth: The Bearish Trend Is Not Expected to Relieve

The move would open up the New York metro region to the cannabis industry.

Legal Cannabis Sales to Begin April 21 in New Jersey. What It Means for Weed Stocks.

News for Canopy Growth Stock (CGC)